Their utility as prognostic markers for renal disease, which has a high prevalence among patients with AAV, may have limitations given that MPO and PR3 are not expressed on the glomerular endothelium. The gene discussed is PRTN3; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.